Defiance Daily Target 2X Long HIMS ETF(HIMZ)

upturn advisory logo
EXPLORE ADVISORIES AND THEIR HISTORY
QUALITY SIGNAL
1-STAR RATING
PASS
LAST CLOSE
$5.39
11/20/2026
(24-hour delay)

Advisory History & Simulated Performance *

*as per simulation (see disclosures)
  • ALL
  • 1Y
  • 1M
  • 1W
  • BUY Advisory
  • SELL Advisory (Profit)
  • SELL Advisory (Loss)
  • Profit
  • Loss
  • PASS (Skip)
Upturn Stock price based on last close iconStock price based on last close
Simulated performance—not actual client returns. Excludes advisory subscription fees, trading commissions, and taxes, which would reduce returns. Results depend on calculation assumptions and do not guarantee future outcomes. See Disclosures for full methodology, assumptions, and limitations.

Advisory Performance History (Simulated)Advisory Performance History info

Simulated performance—not actual client returns. Excludes advisory subscription fees, trading commissions, and taxes, which would reduce returns. Results depend on calculation assumptions and do not guarantee future outcomes. See Disclosures for full methodology, assumptions, and limitations.

Upturn Advisory & Investor View for HIMZ

11/20/2026: HIMZ (1-star) is currently NOT-A-BUY. Pass it for now.

Defiance Daily Target 2X Long HIMS ETF (HIMZ) provides 2x daily leveraged exposure to the performance of Hims & Hers Health, Inc. (HIMS) using swap contracts and financial derivatives. Its primary strengths lie in offering efficient tactical upside amplification for short-term traders without needing a margin account. The fund serves as a short-term trading instrument rather than a long-term investment vehicle. Key risks include severe volatility decay over extended periods, high single-stock concentration, and a 1.33% expense ratio. It suits active momentum traders who closely monitor market positions and should be avoided by long-term passive investors.

How to Read the Upturn Advisory

The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.

ETF holdings, costs, diversification, valuation, risks, and market conditions provide supporting context about the fund.

Investor Fit

Investor styleFitWhy
Growth investorWeak fitLeveraged single-stock ETFs are designed for short-term tactical trading rather than long-term capital growth.
Momentum investorStrong fit while signal remains positiveActive momentum traders can use HIMZ to amplify short-term upside trends in HIMS stock when technical indicators are favorable.
Value investorWeak fitThe fund's heavy reliance on derivatives and high daily turnover counters traditional value investment philosophies.
Dividend/Income investorWeak fitHIMZ does not focus on capital preservation or stable dividend generation.
Low-risk investorWeak fitExtreme volatility and daily compounding risks make this product completely unsuitable for low-risk profiles.

Investor Profile

Ideal Investor Profile

The ideal investor is an active short-term trader or market professional with high risk tolerance who monitors positions intraday and seeks tactical 2x exposure to HIMS.

Suitability

Best suited exclusively for active short-term tactical trading rather than buy-and-hold investing.

Risk Profile

Risk factorLevelWhy it matters
VolatilityHighAmplified daily tracking targets guarantee severe price swings and compounding volatility decay over time.
Market riskHighThe fund is completely exposed to adverse price movements in Hims & Hers Health.
ConcentrationHighPerformance is entirely dependent on a single underlying equity asset.
Tracking/expenseMedium / highCompounding effects over multiple sessions mean multi-day returns will diverge from a clean 2x multiple of the underlying stock.
LiquidityMediumWhile daily volume is generally active, sudden shifts in underlying stock interest can widen spreads.
Business/sector qualityMedium / highInvestors face structural risks tied specifically to the telehealth and digital wellness execution of HIMS.

Sector & Industry Intelligence

This fund is not assigned to one sector.

Risk Analysis

Volatility

HIMZ experiences extreme historical volatility driven by its 2x daily leveraged objective applied to a high-beta growth stock.

Market Risk

The fund carries intense single-issuer risk, meaning any negative operational, competitive, or regulatory event affecting Hims & Hers Health directly impacts the fund's value.

What the ETF Owns

Exposure TypeExposureWeight (%)Retail Investor Read
Single stockHims & Hers Health Inc. (HIMS) — seeks 2x daily return100Provides leveraged derivative exposure tied directly to the daily price fluctuations of Hims & Hers Health.

Price Behavior

Steep Decline
PRICE PATH

Steep Decline

The stock price has dropped sharply with strong downward pressure.

Extreme Price Shocks
PRICE STABILITY

Extreme Price Shocks

The stock has experienced exceptionally large and disruptive price movements during the period.

Analysis of Past Performance

Type ETF
Historic Profit -41.22%
Avg. Invested days 10
Today’s Advisory PASS
Upturn Advisory Rating upturn star rating icon
Upturn Advisory Performance Upturn Advisory Performance icon 1.0
ETF Returns Performance Upturn Returns Performance icon 1.0
Upturn Profits based on simulation icon Profits based on simulation
Upturn last close icon Last Close 11/20/2026
Form CRS provides a relationship summary of our automated advisory services, flat subscription fees, and conflicts of interest. Form ADV Part 2A brochure contains complete details on services, billing, and disclosures. If any summary differs from our current regulatory filings, the filed Form ADV controls.